Annual Revenue
$6.75 B
-$12.12 B-64.22%
31 December 2023
Summary:
Moderna annual revenue is currently $6.75 billion, with the most recent change of -$12.12 billion (-64.22%) on 31 December 2023. During the last 3 years, it has risen by +$6.48 billion (+2364.96%). MRNA annual revenue is now -64.22% below its all-time high of $18.88 billion, reached on 31 December 2022.MRNA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$1.85 B
+$1.63 B+739.37%
30 September 2024
Summary:
Moderna quarterly revenue is currently $1.85 billion, with the most recent change of +$1.63 billion (+739.37%) on 30 September 2024. Over the past year, it has increased by +$68.00 million (+3.81%). MRNA quarterly revenue is now -73.31% below its all-time high of $6.95 billion, reached on 31 December 2021.MRNA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$5.06 B
+$68.00 M+1.36%
30 September 2024
Summary:
Moderna TTM revenue is currently $5.06 billion, with the most recent change of +$68.00 million (+1.36%) on 30 September 2024. Over the past year, it has dropped by -$4.03 billion (-44.38%). MRNA TTM revenue is now -77.31% below its all-time high of $22.28 billion, reached on 30 June 2022.MRNA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -64.2% | +3.8% | -44.4% |
| 3 y3 years | +2365.0% | -61.6% | -54.1% |
| 5 y5 years | +5412.9% | +10000.0% | +7092.1% |
MRNA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.2% | +2365.0% | -73.3% | +1010.8% | -77.3% | +1.4% |
| 5 y | 5 years | -64.2% | >+9999.0% | -73.3% | >+9999.0% | -77.3% | >+9999.0% |
| alltime | all time | -64.2% | >+9999.0% | -73.3% | >+9999.0% | -77.3% | >+9999.0% |
Moderna Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.85 B(+739.4%) | $5.06 B(+1.4%) |
| June 2024 | - | $221.00 M(+32.3%) | $4.99 B(-1.9%) |
| Mar 2024 | - | $167.00 M(-94.1%) | $5.08 B(-24.7%) |
| Dec 2023 | $6.75 B(-64.2%) | $2.81 B(+57.4%) | $6.75 B(-25.7%) |
| Sept 2023 | - | $1.79 B(+465.5%) | $9.09 B(-13.6%) |
| June 2023 | - | $316.00 M(-82.8%) | $10.52 B(-28.8%) |
| Mar 2023 | - | $1.84 B(-64.3%) | $14.77 B(-21.7%) |
| Dec 2022 | $18.88 B(+6.4%) | $5.15 B(+59.9%) | $18.88 B(-8.7%) |
| Sept 2022 | - | $3.22 B(-29.5%) | $20.68 B(-7.2%) |
| June 2022 | - | $4.57 B(-23.1%) | $22.28 B(+1.6%) |
| Mar 2022 | - | $5.94 B(-14.5%) | $21.93 B(+23.7%) |
| Dec 2021 | $17.74 B(+6373.0%) | $6.95 B(+43.9%) | $17.74 B(+61.0%) |
| Sept 2021 | - | $4.83 B(+14.6%) | $11.02 B(+77.7%) |
| June 2021 | - | $4.21 B(+141.8%) | $6.20 B(+207.9%) |
| Mar 2021 | - | $1.74 B(+661.1%) | $2.01 B(+634.7%) |
| Dec 2020 | $274.00 M(+470.8%) | $229.00 M(+1808.3%) | $274.00 M(+393.5%) |
| Sept 2020 | - | $12.00 M(-58.6%) | $55.52 M(-2.4%) |
| June 2020 | - | $29.00 M(+625.0%) | $56.85 M(+50.1%) |
| Mar 2020 | - | $4.00 M(-62.0%) | $37.88 M(-21.1%) |
| Dec 2019 | $48.00 M(-60.8%) | $10.52 M(-21.2%) | $48.00 M(-31.7%) |
| Sept 2019 | - | $13.34 M(+33.0%) | $70.30 M(-24.9%) |
| June 2019 | - | $10.03 M(-28.9%) | $93.62 M(-14.4%) |
| Mar 2019 | - | $14.12 M(-57.0%) | $109.42 M(-10.9%) |
| Dec 2018 | $122.51 M(-30.8%) | $32.82 M(-10.5%) | $122.77 M(-31.2%) |
| Sept 2018 | - | $36.66 M(+41.9%) | $178.37 M(+25.9%) |
| June 2018 | - | $25.83 M(-5.9%) | $141.71 M(+22.3%) |
| Mar 2018 | - | $27.46 M(-68.9%) | $115.88 M(+31.1%) |
| Dec 2017 | $176.97 M(+74.3%) | $88.42 M(>+9900.0%) | $88.42 M(>+9900.0%) |
| Dec 2016 | $101.54 M(>+9900.0%) | - | - |
| Dec 2015 | $680.00 K(+36.0%) | $200.00 K(+150.0%) | $680.00 K(-30.6%) |
| Sept 2015 | - | $80.00 K(-80.0%) | $980.00 K(+8.9%) |
| June 2015 | - | $400.00 K(-20.0%) | $900.00 K(+80.0%) |
| Dec 2014 | $500.00 K(-76.4%) | $500.00 K(-50.0%) | $500.00 K(-76.4%) |
| Dec 2013 | $2.12 M(-49.8%) | $1.00 M(+25.0%) | $2.12 M(-13.2%) |
| Sept 2013 | - | $800.00 K(+154.0%) | $2.44 M(-11.2%) |
| June 2013 | - | $315.00 K(-76.2%) | $2.74 M(-35.0%) |
| Dec 2012 | $4.22 M(+88.6%) | $1.32 M(+19.5%) | $4.22 M(-6.3%) |
| Sept 2012 | - | $1.11 M(-33.3%) | $4.50 M(+22.3%) |
| June 2012 | - | $1.66 M(+1165.6%) | $3.68 M(+71.0%) |
| Mar 2012 | - | $131.00 K(-91.8%) | $2.15 M(-3.7%) |
| Dec 2011 | $2.24 M(-9.1%) | $1.61 M(+461.9%) | $2.24 M(+41.3%) |
| Sept 2011 | - | $286.00 K(+121.7%) | $1.58 M(-34.8%) |
| June 2011 | - | $129.00 K(-39.7%) | $2.43 M(-2.6%) |
| Mar 2011 | - | $214.00 K(-77.5%) | $2.49 M(+1.2%) |
| Dec 2010 | $2.46 M(-83.3%) | $953.00 K(-15.7%) | $2.46 M(+43.4%) |
| Sept 2010 | - | $1.13 M(+485.5%) | $1.72 M(+164.3%) |
| June 2010 | - | $193.00 K(+4.9%) | $649.00 K(-15.2%) |
| Mar 2010 | - | $184.00 K(-11.5%) | $765.00 K(-94.8%) |
| Dec 2009 | $14.73 M(+464.7%) | $208.00 K(+225.0%) | $14.73 M(+0.1%) |
| Sept 2009 | - | $64.00 K(-79.3%) | $14.71 M(-2.3%) |
| June 2009 | - | $309.00 K(-97.8%) | $15.05 M(-2.9%) |
| Mar 2009 | - | $14.15 M(+7467.4%) | $15.50 M(+494.0%) |
| Dec 2008 | $2.61 M(-85.6%) | $187.00 K(-53.8%) | $2.61 M(-70.4%) |
| Sept 2008 | - | $405.00 K(-46.3%) | $8.81 M(-14.5%) |
| June 2008 | - | $754.00 K(-40.3%) | $10.30 M(-28.5%) |
| Mar 2008 | - | $1.26 M(-80.2%) | $14.41 M(-20.6%) |
| Dec 2007 | $18.14 M | $6.39 M(+236.7%) | $18.14 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2007 | - | $1.90 M(-61.0%) | $16.57 M(-18.0%) |
| June 2007 | - | $4.86 M(-2.6%) | $20.21 M(-24.5%) |
| Mar 2007 | - | $4.99 M(+3.7%) | $26.76 M(-6.1%) |
| Dec 2006 | $28.49 M(+282.5%) | $4.82 M(-13.1%) | $28.49 M(+14.1%) |
| Sept 2006 | - | $5.54 M(-51.4%) | $24.97 M(+20.9%) |
| June 2006 | - | $11.41 M(+69.9%) | $20.65 M(+90.5%) |
| Mar 2006 | - | $6.72 M(+419.2%) | $10.84 M(+45.5%) |
| Dec 2005 | $7.45 M(+303.3%) | $1.29 M(+5.8%) | $7.45 M(-2.1%) |
| Sept 2005 | - | $1.22 M(-23.7%) | $7.61 M(+15.5%) |
| June 2005 | - | $1.60 M(-51.9%) | $6.59 M(+31.0%) |
| Mar 2005 | - | $3.33 M(+129.5%) | $5.03 M(+172.3%) |
| Dec 2004 | $1.85 M(-90.5%) | $1.45 M(+614.8%) | $1.85 M(+41.3%) |
| Sept 2004 | - | $203.00 K(+351.1%) | $1.31 M(-18.2%) |
| June 2004 | - | $45.00 K(-69.6%) | $1.60 M(-90.7%) |
| Mar 2004 | - | $148.00 K(-83.8%) | $17.27 M(-11.2%) |
| Dec 2003 | $19.44 M(+117.9%) | $911.00 K(+84.4%) | $19.44 M(-4.2%) |
| Sept 2003 | - | $494.00 K(-96.9%) | $20.29 M(-6.8%) |
| June 2003 | - | $15.72 M(+578.4%) | $21.78 M(+124.2%) |
| Mar 2003 | - | $2.32 M(+31.9%) | $9.71 M(+8.9%) |
| Dec 2002 | $8.92 M(+242.8%) | $1.76 M(-11.5%) | $8.92 M(+19.1%) |
| Sept 2002 | - | $1.99 M(-45.7%) | $7.49 M(+18.6%) |
| June 2002 | - | $3.66 M(+139.7%) | $6.31 M(+85.1%) |
| Mar 2002 | - | $1.52 M(+370.7%) | $3.41 M(+31.0%) |
| Dec 2001 | $2.60 M(-37.1%) | $324.00 K(-60.0%) | $2.60 M(-26.9%) |
| Sept 2001 | - | $809.00 K(+7.4%) | $3.56 M(-9.0%) |
| June 2001 | - | $753.00 K(+5.0%) | $3.91 M(-1.6%) |
| Mar 2001 | - | $717.00 K(-44.2%) | $3.98 M(-4.0%) |
| Dec 2000 | $4.14 M(-8.9%) | $1.28 M(+10.7%) | $4.14 M(+6.1%) |
| Sept 2000 | - | $1.16 M(+42.3%) | $3.90 M(+3.2%) |
| June 2000 | - | $815.00 K(-7.6%) | $3.78 M(-7.0%) |
| Mar 2000 | - | $882.00 K(-15.8%) | $4.07 M(-11.3%) |
| Dec 1999 | $4.55 M(-44.2%) | $1.05 M(+0.9%) | $4.58 M(-2.2%) |
| Sept 1999 | - | $1.04 M(-5.6%) | $4.69 M(-18.5%) |
| June 1999 | - | $1.10 M(-21.4%) | $5.75 M(-22.8%) |
| Mar 1999 | - | $1.40 M(+22.0%) | $7.45 M(-8.6%) |
| Dec 1998 | $8.15 M(+98.7%) | $1.15 M(-45.3%) | $8.15 M(+0.6%) |
| Sept 1998 | - | $2.10 M(-25.0%) | $8.10 M(+15.7%) |
| June 1998 | - | $2.80 M(+33.3%) | $7.00 M(+32.1%) |
| Mar 1998 | - | $2.10 M(+90.9%) | $5.30 M(+32.5%) |
| Dec 1997 | $4.10 M(+115.8%) | $1.10 M(+10.0%) | $4.00 M(+37.9%) |
| Sept 1997 | - | $1.00 M(-9.1%) | $2.90 M(-3.3%) |
| June 1997 | - | $1.10 M(+37.5%) | $3.00 M(-9.1%) |
| Mar 1997 | - | $800.00 K(-27.3%) | $3.30 M(-21.4%) |
| Dec 1996 | $1.90 M(-51.3%) | - | - |
| Sept 1996 | - | $1.10 M(-21.4%) | $4.20 M(+7.7%) |
| June 1996 | $3.90 M(+34.5%) | $1.40 M(+40.0%) | $3.90 M(+11.4%) |
| Mar 1996 | - | $1.00 M(+42.9%) | $3.50 M(+9.4%) |
| Dec 1995 | - | $700.00 K(-12.5%) | $3.20 M(+3.2%) |
| Sept 1995 | - | $800.00 K(-20.0%) | $3.10 M(+3.3%) |
| June 1995 | $2.90 M(+38.1%) | $1.00 M(+42.9%) | $3.00 M(+11.1%) |
| Mar 1995 | - | $700.00 K(+16.7%) | $2.70 M(+8.0%) |
| Dec 1994 | - | $600.00 K(-14.3%) | $2.50 M(+8.7%) |
| Sept 1994 | - | $700.00 K(0.0%) | $2.30 M(+9.5%) |
| June 1994 | $2.10 M | $700.00 K(+40.0%) | $2.10 M(+50.0%) |
| Mar 1994 | - | $500.00 K(+25.0%) | $1.40 M(+55.6%) |
| Dec 1993 | - | $400.00 K(-20.0%) | $900.00 K(+80.0%) |
| Sept 1993 | - | $500.00 K | $500.00 K |
FAQ
- What is Moderna annual revenue?
- What is the all time high annual revenue for Moderna?
- What is Moderna annual revenue year-on-year change?
- What is Moderna quarterly revenue?
- What is the all time high quarterly revenue for Moderna?
- What is Moderna quarterly revenue year-on-year change?
- What is Moderna TTM revenue?
- What is the all time high TTM revenue for Moderna?
- What is Moderna TTM revenue year-on-year change?
What is Moderna annual revenue?
The current annual revenue of MRNA is $6.75 B
What is the all time high annual revenue for Moderna?
Moderna all-time high annual revenue is $18.88 B
What is Moderna annual revenue year-on-year change?
Over the past year, MRNA annual revenue has changed by -$12.12 B (-64.22%)
What is Moderna quarterly revenue?
The current quarterly revenue of MRNA is $1.85 B
What is the all time high quarterly revenue for Moderna?
Moderna all-time high quarterly revenue is $6.95 B
What is Moderna quarterly revenue year-on-year change?
Over the past year, MRNA quarterly revenue has changed by +$68.00 M (+3.81%)
What is Moderna TTM revenue?
The current TTM revenue of MRNA is $5.06 B
What is the all time high TTM revenue for Moderna?
Moderna all-time high TTM revenue is $22.28 B
What is Moderna TTM revenue year-on-year change?
Over the past year, MRNA TTM revenue has changed by -$4.03 B (-44.38%)